These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 17223695)

  • 1. Structure-guided peptidomimetic design leads to nanomolar beta-hairpin inhibitors of the Tat-TAR interaction of bovine immunodeficiency virus.
    Athanassiou Z; Patora K; Dias RL; Moehle K; Robinson JA; Varani G
    Biochemistry; 2007 Jan; 46(3):741-51. PubMed ID: 17223695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural mimicry of retroviral tat proteins by constrained beta-hairpin peptidomimetics: ligands with high affinity and selectivity for viral TAR RNA regulatory elements.
    Athanassiou Z; Dias RL; Moehle K; Dobson N; Varani G; Robinson JA
    J Am Chem Soc; 2004 Jun; 126(22):6906-13. PubMed ID: 15174860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
    Smith CA; Crotty S; Harada Y; Frankel AD
    Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a cyclic peptide that targets a viral RNA.
    Runyon ST; Puglisi JD
    J Am Chem Soc; 2003 Dec; 125(51):15704-5. PubMed ID: 14677935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAR RNA recognition by a cyclic peptidomimetic of Tat protein.
    Leeper TC; Athanassiou Z; Dias RL; Robinson JA; Varani G
    Biochemistry; 2005 Sep; 44(37):12362-72. PubMed ID: 16156649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tethering of proteins to RNAs using the bovine immunodeficiency virus-Tat peptide and BIV-TAR RNA.
    Wakiyama M; Kaitsu Y; Muramatsu R; Takimoto K; Yokoyama S
    Anal Biochem; 2012 Aug; 427(2):130-2. PubMed ID: 22617800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative binding study of modified bovine immunodeficiency virus TAR RNA against its TAT peptide.
    Tok JB; Bi L; Huang S
    Bioorg Med Chem Lett; 2004 Dec; 14(24):6101-5. PubMed ID: 15546738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design of a dimeric RNA-peptide complex.
    Campisi DM; Calabro V; Frankel AD
    EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamics and solvation dynamics of BIV TAR RNA-Tat peptide interaction.
    Goel T; Kumar S; Maiti S
    Mol Biosyst; 2013 Jan; 9(1):88-98. PubMed ID: 23114563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
    Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
    Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative binding study of BIV Tat peptide against its TAR RNA duplex, RNA-DNA heteroduplex and DNA duplex.
    Tok JB; Bi L
    Bioorg Med Chem Lett; 2005 Jan; 15(1):129-33. PubMed ID: 15582425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized influence of 2'-hydroxyl groups and helix geometry on protein recognition in the RNA major groove.
    Landt SG; Tipton AR; Frankel AD
    Biochemistry; 2005 May; 44(17):6547-58. PubMed ID: 15850388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural model of the HIV-1 Tat(46-58)-TAR complex.
    Seewald MJ; Metzger AU; Willbold D; Rösch P; Sticht H
    J Biomol Struct Dyn; 1998 Dec; 16(3):683-92. PubMed ID: 10052624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyamidoamine dendrimers inhibit binding of Tat peptide to TAR RNA.
    Zhao H; Li J; Xi F; Jiang L
    FEBS Lett; 2004 Apr; 563(1-3):241-5. PubMed ID: 15063756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular recognition in the bovine immunodeficiency virus Tat peptide-TAR RNA complex.
    Ye X; Kumar RA; Patel DJ
    Chem Biol; 1995 Dec; 2(12):827-40. PubMed ID: 8807816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of HIV-1 Tat(32-72) with its target RNA: a fluorescence and nuclear magnetic resonance study.
    Metzger AU; Bayer P; Willbold D; Hoffmann S; Frank RW; Goody RS; Rösch P
    Biochem Biophys Res Commun; 1997 Dec; 241(1):31-6. PubMed ID: 9405229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
    Cao H; Tamilarasu N; Rana TM
    Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
    Lu J; Nguyen L; Zhao L; Xia T; Qi X
    Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.